FREE Case Review (866) 588-0600

How to File an Avandia Lawsuit

sc-no-longer-accepting-cases

 

Lawsuits against GlaxoSmithKline have sought damages for people who have developed side effects as a result of taking Avandia.

*** Avandia® Labeling Update 2/4/11: The FDA has notified healthcare professionals and patients that information on the cardiovascular risks (including heart attack) of Avandia (rosiglitazone) has been added to the physician labeling and patient Medication Guide. Additionally, the drug labels have been revised to state that rosiglitazone and rosiglitazone-containing medicines should only be used:

  • In patients already being treated with these medicines
  • In patients whose blood sugar cannot be controlled with other anti-diabetic medicines and who, after consulting with their healthcare professional, do not wish to use pioglitazone-containing medicines (Actos, Actoplus Met, Actoplus Met XR, or Duetact).

Information on how to Initiate an Avandia Lawsuit

To initiate an Avandia lawsuit, injured parties (or loved ones of injured parties) should consult with an experienced defective drug lawyer for a free consultation. At this time, perspective plaintiffs can receive a thorough evaluation of their case along with sound advice regarding the appropriate manner in which to pursue a claim. Avandia lawyers are experienced at providing aggressive, professional representation to injured patients to help them win the settlements they deserve.

Why Should I Pursue an Avandia Lawsuit Against GlaxoSmithKline?

Those who decide to stand up for their legal rights and hold GSK responsible for their injuries may be compensated for their:

  • Medical bills
  • Disabilities
  • Pain & suffering
  • Treatment costs
  • Lost wages
  • In the event that an Avandia death has occurred, funeral and burial expenses

Free Confidential Case Evaluation

Verified 100% Secure SiteTo contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (866) 588-0600.
*
*
*
Awards & recognition